Deferred Tax Assets, Net of Valuation Allowance of ACCENDRA HEALTH INC/VA/ from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
ACCENDRA HEALTH INC/VA/ quarterly Deferred Tax Assets, Net of Valuation Allowance in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • ACCENDRA HEALTH INC/VA/ Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 31 Dec 2025 was $202,420,000, a 80% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)

ACCENDRA HEALTH INC/VA/ Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $202,420,000 +$89,815,000 +80% 31 Dec 2025 10-K 20 Feb 2026 2025 FY
Q4 2024 $112,605,000 -$106,078,000 -49% 31 Dec 2024 10-K 20 Feb 2026 2025 FY
Q4 2023 $218,683,000 -$6,708,000 -3% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q4 2022 $225,391,000 +$92,664,000 +70% 31 Dec 2022 10-K 20 Feb 2024 2023 FY
Q4 2021 $132,727,000 +$15,416,000 +13% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q4 2020 $117,311,000 -$17,536,000 -13% 31 Dec 2020 10-K 23 Feb 2022 2021 FY
Q4 2019 $134,847,000 +$51,479,000 +62% 31 Dec 2019 10-K 24 Feb 2021 2020 FY
Q4 2018 $83,368,000 +$21,807,000 +35% 31 Dec 2018 10-K 04 Mar 2020 2019 FY
Q4 2017 $61,561,000 -$8,724,000 -12% 31 Dec 2017 10-K 06 Mar 2019 2018 FY
Q4 2016 $70,285,000 -$3,301,000 -4.5% 31 Dec 2016 10-K 23 Feb 2018 2017 FY
Q4 2015 $73,586,000 -$553,000 -0.75% 31 Dec 2015 10-K 17 Feb 2017 2016 FY
Q4 2014 $74,139,000 +$11,523,000 +18% 31 Dec 2014 10-K 25 Feb 2016 2015 FY
Q4 2013 $62,616,000 -$4,159,000 -6.2% 31 Dec 2013 10-K 23 Feb 2015 2014 FY
Q4 2012 $66,775,000 +$3,715,000 +5.9% 31 Dec 2012 10-K 25 Feb 2014 2013 FY
Q4 2011 $63,060,000 +$5,505,000 +9.6% 31 Dec 2011 10-K 22 Feb 2013 2012 FY
Q4 2010 $57,555,000 31 Dec 2010 10-K 24 Feb 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.